Delivery Order SPE2DB24D9801-SPE2DB26FKXVM

The Defense Logistics Agency awarded a delivery order valued at $4,677.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Menquadfi vial 0.5ML. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, and was executed on October 29, 2025. No set-aside designation was utilized for this award. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional pharmaceutical suppliers supporting Department of Defense medical supply requirements globally.

DMS Pharmaceutical Group has demonstrated substantial contracting capacity as a critical supplier within the federal pharmaceutical supply chain, with a single-award IDC valued at $499,999,999 through December 31, 2036. The company maintains a comprehensive product portfolio encompassing branded and generic prescription medications, biologics, vaccines, and medical consumables, with performance demonstrated across numerous delivery orders ranging from under $100 to over $115,000. The PPV-G GEN V contract structure includes a 30-month base period with three 30-month option periods, positioning the vendor to serve as a recurring pharmaceutical supplier for military healthcare facilities worldwide under firm fixed-price terms.